E. Jermann
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Neurology top 5%
- Neuroblastoma Research and Treatments
Papers in
-
- Radiopharmaceutical Chemistry and Applications 9
- Medical Imaging Techniques and Applications 3
- Monoclonal and Polyclonal Antibodies Research 2
-
- Neuroendocrine Tumor Research Advances 6
- Co-authors
- Martin Béhé (5 shared papers)Helmut R. Mäcke (5 shared papers)P. Powell (4 shared papers)A. Heppeler (3 shared papers)Michael Hennig (2 shared papers)Sylvie Froidevaux (1 shared paper)Helmut R. Maëcke (4 shared papers)Andreas Otte (2 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (4 papers)International Journal of Cancer (2 papers)Chemistry - A European Journal (2 papers)Scientific Reports (1 paper)PubMed (2 papers)
- Partner nations
- SwitzerlandItalySweden
In The Last Decade
E. Jermann
11 papers receiving 959 citations
Peers
Comparison fields: 5 of 60
- Radiology, Nuclear Medicine and Imaging 581
- Neurology 303
- Oncology 448
- Epidemiology 513
- Genetics 78
Countries citing papers authored by E. Jermann
This map shows the geographic impact of E. Jermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Jermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Jermann more than expected).
Fields of papers citing papers by E. Jermann
This network shows the impact of papers produced by E. Jermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Jermann. The network helps show where E. Jermann may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Jermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 287 | |
| 2 | 1997 | 173 | |
| 3 | 1997 | 171 | |
| 4 | 1999 | 118 | |
| 5 | Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas. | 1999 | 76 |
| 6 | Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y: a phase I study. | 1999 | 61 |
| 7 | 1997 | 54 | |
| 8 | 1997 | 25 | |
| 9 | 1999 | 9 | |
| 10 | 2023 | 7 | |
| 11 | 1997 | 4 |
About E. Jermann
E. Jermann is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology, Genetics, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 11 papers that have together received 985 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (9 papers), Neuroendocrine Tumor Research Advances (6 papers), Medical Imaging Techniques and Applications (3 papers), Nanoplatforms for cancer theranostics (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Glioma Diagnosis and Treatment (2 papers), Advanced X-ray Imaging Techniques (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (581 citations), Neurology (303 citations), Oncology (448 citations), Epidemiology (513 citations) and Genetics (78 citations). E. Jermann has collaborated with scholars based in Switzerland, Italy and Sweden. Frequent co-authors include Martin Béhé, Helmut R. Mäcke, P. Powell, A. Heppeler, Michael Hennig, Sylvie Froidevaux, Helmut R. Maëcke, Andreas Otte, Jan Mueller‐Brand and Marcel E. van der Pluijm. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, International Journal of Cancer, Chemistry - A European Journal, Scientific Reports and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.